| Serial Number | 97916759 |
| Word Mark | CAREEFFECTS |
| Filing Date | Tuesday, May 2, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, December 5, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 9, 2024 |
| Pseudo Mark | CARE EFFECTS |
| Goods and Services | Consultative analytics services namely the collection, reporting, and analysis of healthcare quality data that employs comprehensive, context-of-care risk adjustment to identify individual nurses whose practices significantly impact patient outcomes or treatment; Consultative analytics services namely collection, reporting, and analysis of healthcare quality data that employs comprehensive, context- of-care risk adjustment to identify caregivers whose practices significantly impact opioid or benzodiazepine utilization for reducing excess opioid and benzodiazepine use and improving patient outcomes in hospitals |
| Goods and Services | Medical analysis services relating to the treatment of patients; Providing information and analysis in the fields of nursing, patient outcomes and medication administration; Consultative services in the nature of identifying individual nurses whose practices significantly impact patient outcomes or treatment; Consultative services in the nature of opioid or benzodiazepine utilization, reducing excess opioid and benzodiazepine use and improving patient outcomes in hospitals |
| Goods and Services | Software as a service (SAAS) services featuring software for analyzing patient treatment and patient outcome data; Software as a service (SAAS) services featuring software for analyzing nursing data; Software as a service (SAAS) services featuring software for analyzing patient medication administration data; Software as a service (SAAS) services featuring software identifying individual nurses whose practices significantly impact patient outcomes or treatment; Software as a service (SAAS) services featuring software identifying individual care givers whose practices significantly impact patient opioid or benzodiazepine utilization for reducing excess opioid and benzodiazepine use and improving patient outcomes in hospitals |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 22, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 31, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 31, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Indicator Sciences, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Vestavia Hills, AL 35216 |
| Party Name | Indicator Sciences, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Vestavia Hills, AL 35216 |
| Event Date | Event Description |
| Thursday, February 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 5, 2023 | NEW APPLICATION ENTERED |
| Wednesday, May 31, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 29, 2024 | ASSIGNED TO EXAMINER |
| Thursday, February 8, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, February 8, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, February 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, February 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 9, 2024 | PUBLISHED FOR OPPOSITION |
| Thursday, February 22, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 29, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 20, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, June 4, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, December 4, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 5, 2024 | SOU EXTENSION 1 FILED |
| Thursday, December 5, 2024 | SOU EXTENSION 1 GRANTED |
| Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, June 4, 2025 | TEAS REQUEST TO DIVIDE RECEIVED |
| Wednesday, June 4, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, June 4, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 9, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |